Best practices in contemporary diagnostic immunohistochemistry panel approach to hematolymphoid proliferations

Archives of Pathology and Laboratory Medicine

Volumn 133, Issue 5, 2009, Pages 756-765

  Garcia, Christine F ^a   Swerdlow, Steven H ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD15 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; LEUKOSIALIN; PANEL REACTIVE ANTIBODY; PROTEIN BCL 6; TUMOR MARKER;

ARTICLE; B CELL LYMPHOMA; CANCER DIAGNOSIS; DIAGNOSTIC PROCEDURE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; NONHODGKIN LYMPHOMA; BLOOD DISEASE; CHROMOSOME ANALYSIS; CLASSIFICATION; LYMPHOPROLIFERATIVE DISEASE; METABOLISM; METHODOLOGY; REVIEW; STANDARD;

CYTOGENETIC ANALYSIS; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOPROLIFERATIVE DISORDERS; MOLECULAR DIAGNOSTIC TECHNIQUES; TUMOR MARKERS, BIOLOGICAL;

EID: 65649139610     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008.
2. Cong P, Raffeld M, Teruya-Feldstein J, Sorbara L, Pittaluga S, Jaffe ES. In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. Blood. 2002;99:3376-3382.
3. Nodit L, Bahler DW, Jacobs SA, Locker J, Swerdlow SH. Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes. Hum Pathol. 2003;34:1030-1034.
4. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood. 1997;89:3909-3918.
5. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006;107:265-276.
6. King BE, Chen C, Locker J, et al. Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas. ModPathol. 2000;13:1219-1231.
7. Chen CC, Raikow RB, Sonmez-Alpan E, Swerdlow SH. Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel. Appl Immunohistochem Mol Morphol. 2000;8:1-11.
8. Boudova L, Kazakov DV, Sima R, et al. Cutaneous lymphoid hyperplasia and other lymphoid infiltrates of the breast nipple: a retrospective clinicopathologic study of fifty-six patients. Am J Dermatopathol. 2005;27:375-386.
9. Attygalle AD, Liu H, Shirali S, et al. Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction. Blood. 2004;104:3343-3348.
10. Lee PS, Beneck D, Weisberger J, Gorczyca W. Coexpression of CD43 by benign B cells in the terminal ileum. Appl Immunohistochem Mol Morphol. 2005; 13:138-141.
11. Fu K, Weisenburger DD, Greiner TC, et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood. 2005;106:4315-4321.
12. Swerdlow SH, Williams ME. From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. Hum Pathol. 2002;33: 7-20.
13. O'Malley DP, Vance GH, Orazi A. Chronic lymphocytic leukemia/small lymphocytic lymphoma with trisomy 12 and focal cyclin d1 expression: a potential diagnostic pitfall. Arch Pathol Lab Med. 2005;129:92-95.
14. Pimpinelli N, Berti E, Burg G, et al. Cutaneous follicle centre lymphoma. In: LeBoit PE, Burg G, Weedon D, Sarasin A, eds. Pathology & Genetics: Skin Tumours. Lyon, France: IARC Press; 2006:196-197. World Health Organization Classification of Tumours.
15. Wang SA, Wang L, Hochberg EP, Muzikansky A, Harris NL, Hasserjian RP. Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features. Am J Surg Pathol. 2005;29:1490-1496.
16. Zhang K, Prichard JW, Yoder S, De J, Lin F. Utility of SKP2 and MIB-1 in grading follicular lymphoma using quantitative imaging analysis. Hum Pathol. 2007;38:878-882.
17. Cogliatti SB, Novak U, Henz S, Schmid U, Moller P, Barth TF. Diagnosis of Burkitt lymphoma in due time: a practical approach. Br J Haematol. 2006;134:294-301.
18. Dave SS, Fu K, Wright GW, et al. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med. 2006;354:2431-2442.
19. Hummel M, Bentink S, Berger H, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med. 2006;354:2419-2430.
20. Stein H, Hummel M. Histopathology in the light of molecular profiling. Ann Oncol. 2006;17(suppl 4):iv5-iv7.
21. Haralambieva E, Boerma EJ, van Imhoff GW, et al. Clinical, immunophe- notypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J SurgPathol. 2005;29:1086-1094.
22. Ferry JA. Burkitt's lymphoma: clinicopathologic features and differential diagnosis. Oncologist. 2006;11:375-383.
23. Akasaka T, Akasaka H, Ueda C, et al. Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene. J Clin Oncol. 2000;18:510-518.
24. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275-282.
25. de Jong D, Rosenwald A, Chhanabhai M, et al. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation oftissue microar- ray as a prerequisite for broad clinical applications-a study from the Lunenburg Lymphoma Biomarker Consortium. J Clin Oncol. 2007;25:805-812.
26. Chu PG, Loera S, Huang Q, Weiss LM. Lineage determination of CD20- B-Cell neoplasms: an immunohistochemical study. Am J Clin Pathol. 2006;126:534-544.
27. Rudiger T, Jaffe ES, Delsol G, et al. Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma). Ann Oncol. 1998;9:S31-S8.
28. Browne P, Petrosyan K, Hernandez A, Chan JA. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. Am J Clin Pathol. 2003;120:767-777.
29. Torlakovic E, Torlakovic G, Nguyen PL, Brunning RD, Delabie J. The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker. Am J SurgPathol. 2002;26:1343-1350.
30. Falini B, Mason DY. Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by im-munocytochemistry. Blood. 2002;99:409-426.
31. Vassallo J, Lamant L, Brugieres L, et al. ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's lymphoma: reportof 10 cases. Am J Surg Pathol. 2006;30:223-229.
32. Brauninger A, Wacker HH, Rajewsky K, Kuppers R, Hansmann ML. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma. Cancer Res. 2003;63:1644-1651.
33. Stein H, Marafioti T, Foss HD, et al. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood. 2001;97:496-501.
34. Yao X, Teruya-Feldstein J, Raffeld M, Sorbara L, Jaffe ES. Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall. Mod Pathol. 2001;14:105-110.
35. Quintanilla-Martinez L, Preffer F, Rubin D, Ferry JA, Harris NL. CD20 + T-cell lymphoma: neoplastic transformation of a normal T-cell subset. Am J Clin Pathol. 1994;102:483-489.
36. Lynch EF, Jones PA, Swerdlow SH. CD43 and CD5 antibodies define four normal and neoplastic B-cell subsets: a three-color flow cytometric study. Cytom-etry. 1995;22:223-231.
37. Youinou P, Pers JO, Jamin C, Lydyard PM. CD5-positive B cells at the crossroads of B cell malignancy and nonorgan-specific autoimmunity. Pathol Biol (Paris). 2000;48:574-576.
38. Dorfman DM, Shahsafaei A. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections. Mod Pathol. 1997;10:859-863.
39. Arber DA, Weiss LM. CD43: a review. Appl Immunohistochem. 1993;1:88-96.
40. Arber DA. CD10: a review. Appl Immunohistochem. 1997;5:125-140.
41. Dogan A, Bagdi E, Munson P, Isaacson PG. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol. 2000;24:846-852.
42. Cook JR, Craig FE, Swerdlow SH. Benign CD10-positiveT cells in reactive lymphoid proliferations and B-cell lymphomas. Mod Pathol. 2003;16:879-885.
43. CookJR, Craig FE, Swerdlow SH. Bcl-2 quantitation by multicolor flow cytometry in neoplastic and benign CD10 positive and CD10 negative B-lym-phocytes. Mod Pathol. 2002;15:989.
44. Strauchen JA, Miller LK. Lymphoid progenitor cells in human tonsils. Int J Surg Pathol. 2003;11:21-24.
45. Hyjek E, Chadburn A, Liu YF, Cesarman E, Knowles DM. BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus. Blood. 2001;97:270-276.
46. Utz GL, Swerdlow SH. Distinction of follicular hyperplasia from follicular lymphoma in B5-fixed tissues: comparison of MT2 and bcl-2 antibodies [see comments]. Hum Pathol. 1993;24:1155-1158.
47. Rushin JM, Riordan GP, Heaton RB, Sharpe RW, Cotelingam JD, Jaffe ES. Cytomegalovirus-infected cells express Leu-M1 antigen: a potential source ofdi-agnostic error. Am J Pathol. 1990;136:989-995.
48. Pellegrini W, Bresciani G, De Zorzi A, Marocolo D, Ungari M, Facchetti F. MMA monoclonal antibody is a superior anti-CD15 reagent for the diagnosis of classical Hodgkin's lymphoma? Haematologica. 2007;92:708-709.
49. Nam-Cha SH, Rondacor G, Sanchez-Verde L, et al. PD-1, a follicular T- cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. Am J SurgPathol. 2008;32:1252-1257.